Charles M. Vollmer

Charles River Laboratories (Netherlands) — Netherlands

Medicine · Health Sciences

76h-index20.0kcitations445works2.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(305), Pancreatitis Pathology and Treatment(148), Gallbladder and Bile Duct Disorders(130), Cholangiocarcinoma and Gallbladder Cancer Studies(37), Esophageal and GI Pathology(31)

Publications432 total

Elucidating the Optimal Use of Mitigation Strategies for Improving Pancreatic Fistula Rates after Pancreatoduodenectomy
Annals of Surgery·2025
Parametric models for personalized surveillance intervals for intraductal papillary mucinous neoplasm (IPMN): a multicentric study.
Pancreatology·2025
A risk-adjusted evaluation of the impact of neoadjuvant therapy on pancreatic fistula development after pancreatoduodenectomy
Surgery·2025
Bariatric Surgery and Incident Development of Obesity-Related Comorbidities
JAMA Network Open·2025· 2 citedOpen Access
Influence of species composition and cultivation condition on peri-implant biofilm dysbiosis in vitro
Frontiers in Oral Health·2025Open Access
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients with Unresectable and Borderline Resectable Pancreatic Cancer
International Journal of Radiation Oncology*Biology*Physics·2025Open Access
Predictors of malignancy in patients undergoing surgery for Mirizzi syndrome
Journal of Gastrointestinal Surgery·2025
Impact of Patient Income and Insurance on Postoperative Mortality After Total Pancreatectomy for Pancreatic Neoplasms
Journal of Surgical Oncology·2025Open Access
Exploring the role of quality of life in surgical decision making for patients undergoing pancreatectomy
The American Journal of Surgery·2025
Endoscopic papillectomy for laterally spreading lesions of the papilla: a propensity score-matched analysis
Endoscopy·2025
A phase 1 dual‐dose escalation study of radiation and nab‐paclitaxel in patients with unresectable and borderline resectable pancreatic cancer
Cancer·2025· 1 cited
Histologic- and Genomic-Directed Adjuvant Therapy for Ampullary Adenocarcinoma: A Hidden Genome–Derived Analysis
Journal of the National Comprehensive Cancer Network·2025· 1 citedOpen Access
Development and validation of the SDLD score: a simplified tool to predict successful endoscopic papillectomy in ampullary lesions
Gastrointestinal Endoscopy·2025· 2 citedOpen Access
Pancreatic Fistula After Minimally Invasive and Open Pancreatoduodenectomy
JAMA Surgery·2025
Influence of species composition and cultivation condition on peri-implant biofilm dysbiosis in vitro
2025Open Access
386: IMPROVING FISTULA RATES FOR PANCREATODUODENECTOMY BY TARGETING THE MOST CLINICALLY IMPACTFUL RISK SCENARIOS WITH OPTIMAL MITIGATION
Gastroenterology·2025
Personalized Surveillance Intervals for Intraductal Papillary Mucinous Neoplasm (IPMN)
Annals of Surgery·2025· 2 citedOpen Access
Untangling the Postoperative Upper GI Tract: Imaging Appearance of Altered Anatomy and Its Complications
Applied Radiology·2025
Operating in the realm of uncertainty: the “Fear Factor”
Updates in Surgery·2025Open Access
Prevention, Prediction, and Mitigation of Pancreatic Fistula
2025
page 1 of 22Next →

Frequent Co-authors

Claudio Bassi(17), Mark P. Callery(15), Horacio J. Asbun(13), Shailesh V. Shrikhande(12), Kevin C. Conlon(11), Marc G. Besselink(11), Christos Dervenis(10), Keith D. Lillemoe(10), Jeffrey A. Drebin(10), Tara S. Kent(9), Mustapha Adham(9), Jakob R. Izbicki(9), Stephen W. Behrman(8), Markus W. Büchler(8), Marco Montorsi(8), John P. Neoptolemos(8), Matthew T. McMillan(8), Richard Charnley(7), Charles J. Yeo(7), Abe Fingerhut(7)